The same approach was applied to the group of 111 patients with APS in order to establish the HR for thrombosis or pregnancy morbidity associated with the aCL/aβ2GPI+(aDI-) and aCL/aβ2GPI+(aDI+) serological profiles (Table 6). This evidence concerns the gene ACLY and autoimmune polyendocrinopathy.